This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
home-builder: Archive
Is Van Eck Emerging Markets A (GBFAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for GBFAX
GBFAXPositive Net Change
equity home-builder mutual-funds
Should You Buy Electrolux AB (ELUXY) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ELUXYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Artisan International Fund Investor (ARTIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for ARTIX
ARTIXPositive Net Change
equity home-builder mutual-funds
Is Hartford Small Company HLS IA (HIASX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for HIASX
HIASXNegative Net Change
equity home-builder mutual-funds
Bear of the Day: Toll Brothers, Inc. (TOL)
by Benjamin Rains
TOL provided downbeat earnings guidance when it posted its Q4 2025 earnings results on December 8, as it faces "soft demand across many markets" and other setbacks that are hitting the entire homebuilding and housing market.
TOLPositive Net Change
home-builder
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MRKRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Edgewood Growth Fund Retail (EGFFX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for EGFFX
EGFFXNegative Net Change
equity home-builder mutual-funds
Is T. Rowe Price Blue Chip Growth I (TBCIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TBCIX
TBCIXNegative Net Change
equity home-builder mutual-funds
Is American Century Ultra Investor (TWCUX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for TWCUX
TWCUXNegative Net Change
equity home-builder mutual-funds
Is Vanguard Total Bond Market Index Institutional (VBTIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VBTIX
VBTIXNo Net Change
equity home-builder mutual-funds